US EditionCenterpiece of GSK's $800M Lancaster County investment under construction
2 Articles
2 Articles
Centerpiece of GSK's $800M Lancaster County investment under construction
A new facility producing up to 40 million doses per year of vaccines for illnesses such as shingles and respiratory syncytial virus is expected to be up and running at GSK’s campus near Marietta in 2028.
Lancaster County expansion project expected to create, maintain jobs - Central Penn Business Journal
Global biopharma company GSK has broken ground on its Lancaster County project, which is expected to inject more than $800 million into the Pennsylvania economy and create and maintain jobs. Gov. Josh Shapiro announced in October GSK’s $800 million project that is expected to create at least 200 new jobs and retain 4,622 employees while boosting the state’s life sciences industry. Along with its expansion in Lancaster County, GSK will keep its U…
Coverage Details
Bias Distribution
- 100% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
